CRH said its full-year 2023 total revenues were $34.9 billion (+7%), income from continuing operations was $3.1 billion (+14%), Adjusted EBITDA was $6.2 billion (+15%), and net cash provided by operating activities was $5.0 billion.

1. 01

   CRH said its full-year 2023 total revenues were $34.9 billion (+7%), income from continuing operations was $3.1 billion (+14%), Adjusted EBITDA was $6.2 billion (+15%), and net cash provided by operating activities was $5.0 billion.

2. 02

   CRH said EPS from continuing operations for 2023 was $4.36 (+22%), and excluding non-cash impairment charges, it was $4.65 (+30%). The non-cash impairment charges related to the Philippines business were $0.3 billion.

3. 03

   CRH said it repurchased 54.9 million ordinary shares in 2023 for a total consideration of $3.0 billion. The full-year dividend for 2023 was $1.33 per share (+5%), and the board declared a new quarterly dividend of $0.35 per share.

4. 04

   CRH said its full-year outlook for 2024 calls for net income of $3.55 to $3.80 billion, Adjusted EBITDA of $6.55 to $6.85 billion, EPS of $5.15 to $5.45, and capital expenditure of $2.2 to $2.4 billion.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.